domingo, 8 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 15, 2026

E-Learning Research Report 2026-2031: Extensive Product Portfolios, Robust LMS Platforms, and Institutional Partnerships Consolidate Market Leadership

View original at globenewswire.com
E-Learning Research Report 2026-2031: Extensive Product Portfolios, Robust LMS Platforms, and Institutional Partnerships Consolidate Market Leadership Dublin, Jan…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • EU GDP was 1.0% higher in real terms in 2024 than in 2023

    80% confidence
  • China is growing at a CAGR of 16.15% during the forecast period

    80% confidence
  • APAC is the second largest share and fastest growing market of the global e-learning market

    80% confidence
  • The global e-learning market is moderately concentrated and highly competitive

    80% confidence
  • The E-Learning Market was valued at USD 325 Billion in 2025, and is projected to reach USD 665.06 Billion by 2031, rising at a CAGR of 12.68%

    80% confidence
  • The market faces challenges from proliferation of low-cost, open-access, and unregulated content providers, particularly in developing regions

    80% confidence
  • Kahoot! has 8 million teachers and 1.6 billion users globally in 2024

    80% confidence
  • North America is the largest e-learning market in 2025, with the US accounting for over 80% of the region

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,996
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,996 factos verificados com a fonte5,552 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
E-Learning Research Report 2026-2031: Extensive Product Portfolios, Robust LMS Platforms, and Institutional Partnerships Consolidate Market Leadership — Source | Via News | pt.VIA.NEWS